- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06620471
Assessing the Enhanced Precision: The Value of Impedance in Ultrasound-Guided Nerve Blocks (Axillary, Interscalene, Popliteal Sciatic), an Exploratory Prospective Observational Study
May 18, 2026 updated by: Georges Assaf, Lebanese American University
Assessing the Enhanced Precision: The Value of Impedance in Ultrasound-Guided Nerve Blocks, an Exploratory Prospective Observational Study
Impedance can have an impact on nerve block during loco-regional anesthesia, particularly when using techniques such as nerve stimulation or ultrasound guidance to locate and block specific nerves.
Impedance refers to the resistance to electrical current flow within tissue, and it can affect the ability to stimulate nerves or visualize them using ultrasound.
The aim of this research is to assess the impedance across different tissue type during an axillary peripheral nerve block (skin, fat, fascia, muscle, nerve proximity).
The results of this study would help clinicians performing nerve block to enhance the precision of needle placement, thus increase the success rate of nerve block and reduce adverse events such as intraneural or intravascular injections.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Assaf, M.D. Anesthesiology
- Phone Number: +961 3 970 762
- Email: georges.assaf@laumcrh.com
Study Contact Backup
- Name: Michel Youssef Akiki, M.D. anesthesiology resident
- Phone Number: + 961 71159586
- Email: michel.akiki@lau.edu
Study Locations
-
-
Beirut
-
Beirut, Beirut, Lebanon
- Recruiting
- Lebanese American University Rizk Hospital
-
Contact:
- Assaf, M.D. Anesthesiology
- Phone Number: +961 3 970 762
- Email: georges.assaf@laumcrh.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Community sample
Description
Inclusion Criteria:
- Individuals aged 18 years to 90 years old
- No infection at the injection site
- Patient signed the study consent form
- No contraindications for nerve block
- No allergies to any of the drugs used
- Patient able to communicate effectively
Exclusion Criteria:
- Patients not meeting the inclusion criteria
- Patients with bleeding disorders or undergoing anticoagulation therapy
- Pregnant patients
- Patients with mental incapacity
- Any medical conditions posing severe risks during the procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess the impedance across different type of tissue during axillary, popliteal and interscalene nerve block
Time Frame: Two years
|
Measure impedance at different locations, different tissue types and different distances from the nerve (as recorded on the nerve stimulator)
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
September 21, 2024
First Submitted That Met QC Criteria
September 28, 2024
First Posted (Actual)
October 1, 2024
Study Record Updates
Last Update Posted (Actual)
May 20, 2026
Last Update Submitted That Met QC Criteria
May 18, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- LAUGPNB5372
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.